{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:08:29Z","timestamp":1793405309591,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,6,1]]},"DOI":"10.1038\/onc.2016.464","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T12:24:06Z","timestamp":1483964646000},"page":"3168-3177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas"],"prefix":"10.1038","volume":"36","author":[{"given":"A","family":"Pemov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Patidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N F","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sindiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S W","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J S","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Elkahloun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S C","family":"Chandrasekharappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"NISC Comparative Sequencing Program","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J F","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"NCI DCEG Cancer Genomics Research Laboratory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Mullikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B C","family":"Widemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D R","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"key":"BFonc2016464_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","volume":"12","author":"K Jett","year":"2010","unstructured":"Jett K, Friedman JM . Clinical and genetic aspects of neurofibromatosis 1. Genet Med 2010; 12: 1\u201311.","journal-title":"Genet Med"},{"key":"BFonc2016464_CR2","doi-asserted-by":"crossref","unstructured":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988; 45: 575\u2013578.","DOI":"10.1001\/archneur.1988.00520290115023"},{"issue":"Pt 6","key":"BFonc2016464_CR3","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","volume":"111","author":"SM Huson","year":"1988","unstructured":"Huson SM, Harper PS, Compston DA . Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 1988; 111 (Pt 6): 1355\u20131381.","journal-title":"Brain"},{"key":"BFonc2016464_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1215\/15228517-2008-011","volume":"10","author":"VF Mautner","year":"2008","unstructured":"Mautner VF, Asuagbor FA, Dombi E, Funsterer C, Kluwe L, Wenzel R et al. Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncol 2008; 10: 593\u2013598.","journal-title":"Neuro Oncol"},{"key":"BFonc2016464_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/jmg.39.5.311","volume":"39","author":"DG Evans","year":"2002","unstructured":"Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A . Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002; 39: 311\u2013314.","journal-title":"J Med Genet"},{"key":"BFonc2016464_CR6","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","volume":"34","author":"E Uusitalo","year":"2016","unstructured":"Uusitalo E, Rantanen M, Kallionpaa RA, Poyhonen M, Leppavirta J, Yla-Outinen H et al. Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol 2016; 34: 1978\u20131986.","journal-title":"J Clin Oncol"},{"key":"BFonc2016464_CR7","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0b013e3181bd1326","volume":"73","author":"A Kim","year":"2009","unstructured":"Kim A, Gillespie A, Dombi E, Goodwin A, Goodspeed W, Fox E et al. Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas. Neurology 2009; 73: 1273\u20131279.","journal-title":"Neurology"},{"key":"BFonc2016464_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.pediatrneurol.2007.01.009","volume":"36","author":"D Babovic-Vuksanovic","year":"2007","unstructured":"Babovic-Vuksanovic D, Widemann BC, Dombi E, Gillespie A, Wolters PL, Toledo-Tamula MA et al. Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas. Pediatr Neurol 2007; 36: 293\u2013300.","journal-title":"Pediatr Neurol"},{"key":"BFonc2016464_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/pbc.25041","volume":"61","author":"BC Widemann","year":"2014","unstructured":"Widemann BC, Babovic-Vuksanovic D, Dombi E, Wolters PL, Goldman S, Martin S et al. Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. Pediatr Blood Cancer 2014; 61: 1598\u20131602.","journal-title":"Pediatr Blood Cancer"},{"key":"BFonc2016464_CR10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/pbc.24873","volume":"61","author":"B Weiss","year":"2014","unstructured":"Weiss B, Widemann BC, Wolters P, Dombi E, Vinks AA, Cantor A et al. Sirolimus for non-progressive NF1-associated plexiform neurofibromas: an NF clinical trials consortium phase II study. Pediatr Blood Cancer 2014; 61: 982\u2013986.","journal-title":"Pediatr Blood Cancer"},{"key":"BFonc2016464_CR11","first-page":"760","volume":"59","author":"J Peltonen","year":"1988","unstructured":"Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, Virtanen I et al. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 1988; 59: 760\u2013771.","journal-title":"Lab Invest"},{"key":"BFonc2016464_CR12","doi-asserted-by":"crossref","unstructured":"Stemmer-Rachamimov A, Nielsen GP. Pathologic and molecular diagnostic features of peripheral nerve sheath tumors in NF1. In: Upadhyaya M, Cooper DN (eds). Neurofibromatosis Type 1: Molecular and Cellular Biology. Springer: Heidlberg, 2012. pp 429\u2013443.","DOI":"10.1007\/978-3-642-32864-0_28"},{"key":"BFonc2016464_CR13","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","volume":"9","author":"E Serra","year":"2000","unstructured":"Serra E, Rosenbaum T, Winner U, Aledo R, Ars E, Estivill X et al. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum Mol Genet 2000; 9: 3055\u20133064.","journal-title":"Hum Mol Genet"},{"key":"BFonc2016464_CR14","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/humu.20389","volume":"27","author":"O Maertens","year":"2006","unstructured":"Maertens O, Brems H, Vandesompele J, De Raedt T, Heyns I, Rosenbaum T et al. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum Mutat 2006; 27: 1030\u20131040.","journal-title":"Hum Mutat"},{"key":"BFonc2016464_CR15","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/hmg\/ddp212","volume":"18","author":"A Sabbagh","year":"2009","unstructured":"Sabbagh A, Pasmant E, Laurendeau I, Parfait B, Barbarot S, Guillot B et al. Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Hum Mol Genet 2009; 18: 2768\u20132778.","journal-title":"Hum Mol Genet"},{"key":"BFonc2016464_CR16","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1136\/jmg.40.10.e109","volume":"40","author":"B Castle","year":"2003","unstructured":"Castle B, Baser ME, Huson SM, Cooper DN, Upadhyaya M . Evaluation of genotype-phenotype correlations in neurofibromatosis type 1. J Med Genet 2003; 40: e109.","journal-title":"J Med Genet"},{"key":"BFonc2016464_CR17","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/jnci\/djr416","volume":"103","author":"E Pasmant","year":"2011","unstructured":"Pasmant E, Sabbagh A, Masliah-Planchon J, Ortonne N, Laurendeau I, Melin L et al. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. J Natl Cancer Inst 2011; 103: 1713\u20131722.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2016464_CR18","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/gcc.20921","volume":"50","author":"E Beert","year":"2011","unstructured":"Beert E, Brems H, Daniels B, De Wever I, Van Calenbergh F, Schoenaers J et al. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors. Genes Chrom Cancer 2011; 50: 1021\u20131032.","journal-title":"Genes Chrom Cancer"},{"key":"BFonc2016464_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1158\/1078-0432.CCR-13-0780","volume":"20","author":"A Luscan","year":"2014","unstructured":"Luscan A, Shackleford G, Masliah-Planchon J, Laurendeau I, Ortonne N, Varin J et al. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis. Clin Cancer Res 2014; 20: 358\u2013371.","journal-title":"Clin Cancer Res"},{"key":"BFonc2016464_CR20","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/ng.3116","volume":"46","author":"M Zhang","year":"2014","unstructured":"Zhang M, Wang Y, Jones S, Sausen M, McMahon K, Sharma R et al. Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors. Nat Genet 2014; 46: 1170\u20131172.","journal-title":"Nat Genet"},{"key":"BFonc2016464_CR21","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/ng.3095","volume":"46","author":"W Lee","year":"2014","unstructured":"Lee W, Teckie S, Wiesner T, Ran L, Prieto Granada CN, Lin M et al. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet 2014; 46: 1227\u20131232.","journal-title":"Nat Genet"},{"key":"BFonc2016464_CR22","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1158\/1078-0432.CCR-14-3049","volume":"21","author":"AC Hirbe","year":"2015","unstructured":"Hirbe AC, Dahiya S, Miller CA, Li T, Fulton RS, Zhang X et al. Whole exome sequencing reveals the order of genetic changes during malignant transformation and metastasis in a single patient with NF1-plexiform neurofibroma. Clin Cancer Res 2015; 21: 4201\u20134211.","journal-title":"Clin Cancer Res"},{"key":"BFonc2016464_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J . A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014; 46: 310\u2013315.","journal-title":"Nat Genet"},{"key":"BFonc2016464_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ng0995-90","volume":"11","author":"SD Colman","year":"1995","unstructured":"Colman SD, Williams CA, Wallace MR . Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 1995; 11: 90\u201392.","journal-title":"Nat Genet"},{"key":"BFonc2016464_CR25","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.18632\/oncotarget.689","volume":"3","author":"K Kannan","year":"2012","unstructured":"Kannan K, Inagaki A, Silber J, Gorovets D, Zhang J, Kastenhuber ER et al. Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma. Oncotarget 2012; 3: 1194\u20131203.","journal-title":"Oncotarget"},{"key":"BFonc2016464_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ng.619","volume":"42","author":"J Barretina","year":"2010","unstructured":"Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, Decarolis PL et al. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet 2010; 42: 715\u2013721.","journal-title":"Nat Genet"},{"key":"BFonc2016464_CR27","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807\u20131812.","journal-title":"Science"},{"key":"BFonc2016464_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 2012; 44: 251\u2013253.","journal-title":"Nat Genet"},{"key":"BFonc2016464_CR29","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1158\/0008-5472.CAN-10-4577","volume":"71","author":"LQ Le","year":"2011","unstructured":"Le LQ, Liu C, Shipman T, Chen Z, Suter U, Parada LF . Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development. Cancer Res 2011; 71: 4686\u20134695.","journal-title":"Cancer Res"},{"key":"BFonc2016464_CR30","volume-title":"Neurofibromatosis Type 1: Molecular and Cellular Biology","author":"J Buchstaller","year":"2012","unstructured":"Buchstaller J, Clapp DW, Parada LF, Zhu Y. Cell of Origin and the Contribution of Microenvironment in NF1 Tumorigenesis and Therapeutic Implications. In: Upadhyaya M, Cooper DN (eds). Neurofibromatosis Type 1: Molecular and Cellular Biology. Springer: Heidelberg, 2012."},{"key":"BFonc2016464_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<117::AID-GCC1>3.0.CO;2-H","volume":"27","author":"MR Wallace","year":"2000","unstructured":"Wallace MR, Rasmussen SA, Lim IT, Gray BA, Zori RT, Muir D . Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors. Genes Chromosomes Cancer 2000; 27: 117\u2013123.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFonc2016464_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/1479-7364-5-6-623","volume":"5","author":"S Laycock-van Spyk","year":"2011","unstructured":"Laycock-van Spyk S, Thomas N, Cooper DN, Upadhyaya M . Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis. Hum Genomics 2011; 5: 623\u2013690.","journal-title":"Hum Genomics"},{"key":"BFonc2016464_CR33","doi-asserted-by":"publisher","first-page":"E103","DOI":"10.1002\/humu.20793","volume":"29","author":"M Upadhyaya","year":"2008","unstructured":"Upadhyaya M, Spurlock G, Monem B, Thomas N, Friedrich RE, Kluwe L et al. Germline and somatic NF1 gene mutations in plexiform neurofibromas. Hum Mutat 2008; 29: E103\u2013E111.","journal-title":"Hum Mutat"},{"key":"BFonc2016464_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1349-7006.1998.tb00472.x","volume":"89","author":"M Emi","year":"1998","unstructured":"Emi M, Matsushima M, Katagiri T, Yoshimoto M, Kasumi F, Yokota T et al. Multiplex mutation screening of the BRCA1 gene in 1000 Japanese breast cancers. Jpn J Cancer Res 1998; 89: 12\u201316.","journal-title":"Jpn J Cancer Res"},{"key":"BFonc2016464_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/ng1122","volume":"33","author":"C Dode","year":"2003","unstructured":"Dode C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi-Yanicostas N et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 2003; 33: 463\u2013465.","journal-title":"Nat Genet"},{"key":"BFonc2016464_CR36","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1158\/1078-0432.CCR-06-0182","volume":"13","author":"P Levy","year":"2007","unstructured":"Levy P, Ripoche H, Laurendeau I, Lazar V, Ortonne N, Parfait B et al. Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1. Clin Cancer Res 2007; 13: 398\u2013407.","journal-title":"Clin Cancer Res"},{"key":"BFonc2016464_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/NEN.0b013e3181c79bff","volume":"69","author":"E Pasmant","year":"2010","unstructured":"Pasmant E, Ortonne N, Rittie L, Laurendeau I, Levy P, Lazar V et al. Differential expression of CCN1\/CYR61, CCN3\/NOV, CCN4\/WISP1, and CCN5\/WISP2 in neurofibromatosis type 1 tumorigenesis. J Neuropathol Exp Neurol 2010; 69: 60\u201369.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFonc2016464_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/emmm.200900027","volume":"1","author":"SJ Miller","year":"2009","unstructured":"Miller SJ, Jessen WJ, Mehta T, Hardiman A, Sites E, Kaiser S et al. Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Mol Med 2009; 1: 236\u2013248.","journal-title":"EMBO Mol Med"},{"key":"BFonc2016464_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.semcdb.2016.06.002","volume":"58","author":"LJ Smithson","year":"2016","unstructured":"Smithson LJ, Anastasaki C, Chen R, Toonen JA, Williams SB, Gutmann DH . Contextual signaling in cancer. Semin Cell Dev Biol 2016; 58: 118\u2013126.","journal-title":"Semin Cell Dev Biol"},{"key":"BFonc2016464_CR40","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/humu.22044","volume":"33","author":"M Upadhyaya","year":"2012","unstructured":"Upadhyaya M, Spurlock G, Thomas L, Thomas NS, Richards M, Mautner VF et al. Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis. Hum Mutat 2012; 33: 763\u2013776.","journal-title":"Hum Mutat"},{"key":"BFonc2016464_CR41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0002-9440(10)63992-2","volume":"158","author":"D Muir","year":"2001","unstructured":"Muir D, Neubauer D, Lim IT, Yachnis AT, Wallace MR . Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. Am J Pathol 2001; 158: 501\u2013513.","journal-title":"Am J Pathol"},{"key":"BFonc2016464_CR42","doi-asserted-by":"publisher","first-page":"e1004575","DOI":"10.1371\/journal.pgen.1004575","volume":"10","author":"A Pemov","year":"2014","unstructured":"Pemov A, Sung H, Hyland PL, Sloan JL, Ruppert SL, Baldwin AM et al. Genetic modifiers of neurofibromatosis Type 1-Associated Cafe-au-Lait macule count identified using multi-platform analysis. PLOS Genet 2014; 10: e1004575.","journal-title":"PLOS Genet"},{"key":"BFonc2016464_CR43","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","volume":"7","author":"C Trapnell","year":"2012","unstructured":"Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012; 7: 562\u2013578.","journal-title":"Nat Protoc"},{"key":"BFonc2016464_CR44","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545\u201315550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016464_CR45","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/neuonc\/nou317","volume":"17","author":"R Dewan","year":"2014","unstructured":"Dewan R, Pemov A, Kim HJ, Butman JA, Morgan K, Vasquez RA et al. Evidence of multiple independent tumor initiation events in neurofibromatosis type 2-associated vestibular schwannomas. Neuro Oncol 2014; 17: 566\u2013573.","journal-title":"Neuro Oncol"},{"key":"BFonc2016464_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 2013; 31: 213\u2013219.","journal-title":"Nat Biotechnol"},{"key":"BFonc2016464_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/bioinformatics\/btq630","volume":"27","author":"A Youn","year":"2011","unstructured":"Youn A, Simon R . Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics 2011; 27: 175\u2013181.","journal-title":"Bioinformatics"},{"key":"BFonc2016464_CR48","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 2009; 25: 2078\u20132079.","journal-title":"Bioinformatics"},{"key":"BFonc2016464_CR49","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1101\/gr.106716.110","volume":"20","author":"JK Teer","year":"2010","unstructured":"Teer JK, Bonnycastle LL, Chines PS, Hansen NF, Aoyama N, Swift AJ et al. Systematic comparison of three genomic enrichment methods for massively parallel DNA sequencing. Genome Res 2010; 20: 1420\u20131431.","journal-title":"Genome Res"},{"key":"BFonc2016464_CR50","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38: e164.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2016464_CR51","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/bioinformatics\/btr711","volume":"28","author":"JK Teer","year":"2012","unstructured":"Teer JK, Green ED, Mullikin JC, Biesecker LG . VarSifter: visualizing and analyzing exome-scale sequence variation data on a desktop computer. Bioinformatics 2012; 28: 599\u2013600.","journal-title":"Bioinformatics"},{"key":"BFonc2016464_CR52","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754\u20131760.","journal-title":"Bioinformatics"},{"key":"BFonc2016464_CR53","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011; 43: 491\u2013498.","journal-title":"Nat Genet"},{"key":"BFonc2016464_CR54","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/bioinformatics\/btl048","volume":"22","author":"F Hsu","year":"2006","unstructured":"Hsu F, Kent WJ, Clawson H, Kuhn RM, Diekhans M, Haussler D . The UCSC known genes. Bioinformatics 2006; 22: 1036\u20131046.","journal-title":"Bioinformatics"},{"key":"BFonc2016464_CR55","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature11404","volume":"489","author":"Cancer Genome Atlas Research N","year":"2012","unstructured":"Cancer Genome Atlas Research N. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012; 489: 519\u2013525.","journal-title":"Nature"},{"key":"BFonc2016464_CR56","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013; 499: 214\u2013218.","journal-title":"Nature"},{"key":"BFonc2016464_CR57","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ng0506-500","volume":"38","author":"M Reich","year":"2006","unstructured":"Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP . GenePattern 2.0. Nat Genet 2006; 38: 500\u2013501.","journal-title":"Nat Genet"},{"key":"BFonc2016464_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-61779-400-1_4","volume":"802","author":"P Van Loo","year":"2012","unstructured":"Van Loo P, Nilsen G, Nordgard SH, Vollan HK, Borresen-Dale AL, Kristensen VN et al. Analyzing cancer samples with SNP arrays. Methods Mol Biol 2012; 802: 57\u201372.","journal-title":"Methods Mol Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2016464","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2016464.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2016.464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/onc2016464.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:08:56Z","timestamp":1647878936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2016464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":58,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2017,6,1]]}},"alternative-id":["BFonc2016464"],"URL":"https:\/\/doi.org\/10.1038\/onc.2016.464","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,9]]},"assertion":[{"value":"23 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}